Agenda - Day 3

There are no agenda items with this track

10:00 am

10:00 am

Networking

Networking

Enter Networking Lounge, Connect with Your Industry Colleagues

  • Get a good start on the day and make connections with industry leadership
  • Join “drop-in” roundtables on most topical issues
  • Schedule 1-2-1 video meetings with peers
  • Gather essential content at virtual exhibit booths

11:00 am

11:00 am

Setting Today’s Plan from your Host

Gather your learning take-aways and key highlights of this event to map the current situation and help in achieving success from today’s event.

11:05 am

11:05 am

Keynote Address: Where is Pharmacare?

Gain Insight into the Impact of Covid-19 on Access to Prescription Medication

The economic impact of the pandemic has been significant for many Canadians, but devastating to those who have lost their jobs and the drug benefit plans they relied on for treatment for their own medical conditions or those of their families.  More than a year has elapsed since the report “A Prescription for Canada: Achieve Pharmacare for All” was issued, and lately it has disappeared from the Federal agenda.  Hear why, as the post-pandemic future emerges, Canadians need it now more than ever.  Shape your market access strategy by:

  • Understanding the impact of Covid-19 on Canadians’ access to prescription medications
  • What steps are currently being taken to encourage the federal government to implement the recommendations in their report
  • What impact implementation may have on Canada’s pharma industry and whether it may need to be coordinated with the launch of the new PMPRB pricing regulations

Get valuable insights on the impact of Covid-19 on how, or whether Canadians can access prescription medication

11:30 am

11:30 am

Keynote Panel Discussion:

Inform your Market Access Strategy with Cross-Border Perspectives on CUSMA, Affordable Drug Prices and Access to Prescription Medicine during Covid-19 and Beyond

One of the consequences of Covid-19 is the problem many people have accessing prescription medication in both Canada and the U.S. because of unemployment and escalating drug costs.  Both Canada and the U.S. have taken steps to address rising costs, so far with limited success.  CUSMA will also have an impact on access going forward.  Gain key insights on:

  • The impact CUSMA may have on IP and Canada’s listing on the ‘Watch List’ of the Office of the U.S. Trade Representative
  • Canada’s future prospects of gaining access to vaccines for Covid-19
  • Progress of drug price containment initiatives of both Canada and the U.S.

Sharpen your North American market access strategies with key insights on cross-border issues

12:00 pm

12:00 pm

Networking

Networking

Build Relationships, Network and Experience Unparalleled Peer-to-Peer Learning

Expand your network and engage in-depth learning with your peers. Take advantage of any format to further build your knowledge and networking base:

  • “Drop-in” virtual Roundtable chats with up to 15 fellow delegates
  • Cozy 3-4 person discussion
  • Engage in 1:1 video conversation with peers or vendors
  • Vendor solution roundtables

12:30 pm

12:30 pm

Explore New Approaches to Developing and Gaining Market Access for Drugs to Treat Rare Diseases

Developing, delivering and funding treatment for patients with rare diseases has become the single biggest challenge for payers, patients and manufacturers.  With a growing consensus that a new drug development model is needed, the question becomes what form should it take?  Gain valuable insights to inform your market access strategy by:

  • Learning what types of partnerships and funding will be key to the successful development of drugs for rare diseases going forward
  • Hearing what impact the increased government funding announced in last fall’s federal budget is having on the pipeline of treatments
  • Understanding what new routes to market and commercialization for these medications may be forged to get them to patients safely and expeditiously

Prepare your organization for a new market access model for treatments for rare diseases.

1:00 pm

1:00 pm

What’s Next for Patient Support Programs?

Patient support programs to allow patients access to specialty medications have now become a mainstay in the marketplace over the past couple of decades.  However, there are shifting market dynamics that will likely require your company to develop a new approach to these critical programs.  Gain insight that will allow your company to take incisive steps in forward planning by:

  • Understanding what tensions are now surfacing between support services required and financial sustainability
  • Determining to what extent the entry of biosimilar PSPs increase competition
  • Hearing what vision may be emerging in how PSPs could be re-designed

Gain an edge in patient retention with an improved PSP

1:20 pm

1:20 pm

Networking

Visit Virtual Booths, Source Content and Engage in Demos with Industry Experts

  • Pose your biggest questions to leading industry vendor experts through 1:1 video conversations or chat.
  • Experience a live demo and understand your options. Source leading-edge content from virtual booths.
  • Walk away satisfied with solutions to your biggest challenges.

1:50 pm

1:50 pm

Panel Discussion

Improve Your Assessment of the Medical Cannabis Market with the Latest Pharmacoeconomics and Health Canada Policy Developments for Pharmacies

The use of medical cannabis has continued to increase in tandem with greater knowledge concerning its effectiveness in treating various disorders.  Decisions regarding whether your organization should include it in your pipeline or formulary need to be backed by an evidence-based approach.  Discover the latest developments in the use of medical cannabis to assist you to:

  • Better understand the opportunities this market represents and evaluate whether the benefits of entering it outweigh the risks of staying out
  • Assess the growing body of evidence that supports the use of medical cannabis especially among older patients
  • Gain insight into how Health Canada is moving forward with policies for cannabis products in pharmacies

Benefit your organization with an evidence-based approach to decisions on medical cannabis

2:20 pm

2:20 pm

Key Take-Aways and Summary from your Host

Hear the key solutions and take-aways from today’s sessions. Source a summary of actions points for you to implement.

2:30 pm

2:30 pm

Networking

Networking Extravaganza and Virtual Happy Hour!

  • Meet informally with fellow delegates in “Drop-in” virtual roundtable chats.
  • Engage in 1:1 video conversation with peers or vendors.
  • Connect with fellow delegates as “recommend matches” based on similar interests and business objectives

3:00 pm

3:00 pm

Conference Day 3 Adjourns

Get the latest news

*Privacy Policy